The Relative Contribution of Amyloid, Tau, Neurodegeneration, and Vascular Disease to Cognition and Cognitive Decline: A Cross‐National Study

TL;DR

This study compares how amyloid, tau, neurodegeneration, and vascular disease affect cognition in the US and South Korea.

Contribution

The study identifies the relative influence of ATNV biomarkers on cognition and decline across two national cohorts.

Findings

T and N are most strongly associated with cognition in both US and South Korean populations.

T is most predictive of future cognitive decline in the US but not in South Korea.

A is associated with memory decline in the US cohort.

Abstract

Recent in vivo biomarker advancements have led to biological diagnostic and staging criteria for AD based on amyloid(“A”), tau(“T”), and neurodegeneration(“N”). However, the contribution of comorbid vascular(“V”) pathology and the relative influence of ATNV on cognitive performance and decline remains unclear, though is necessary to guide personalized diagnosis, prognosis, and care. We assessed the relative contribution of neuroimaging‐based ATNV measures to cognition in cross‐national studies.

Amyloid PET, tau PET, MRI, cognitive testing, and clinical evaluations were obtained in two prospective cohort studies with similar designs: ADNI3 in the US (n = 508; mean age=71±7, female=55%, education(yrs)=16.5±2.3) and KBASE in South Korea (n = 165; age=73±8, female=64%, education(yrs)=11.0±4.6). Continuous ATNV predictors included A=cortical centiloids, T=meta‐temporal SUVR, N = AD‐signature cortical thickness, and V=white matter hyperintensity volume. Clinical diagnoses of cognitively unimpaired (CU), mild cognitive impairment (MCI), and dementia were determined by clinical consensus. Cognitive testing was obtained annually with up to 4 years of follow‐up, and factor scores in each cognitive domain were used as outcomes. Parallel cross‐sectional analyses were performed within each cohort. ANOVA was performed to compare ATNV across clinical diagnoses. Multivariable linear mixed‐effect models were used to assess the association of baseline ATNV predictors with baseline and longitudinal cognitive outcomes adjusting for age, sex, education, and APOE status.

A, T, N, and V as continuous (mean) and binary (frequency of positivity) variables increased with clinical disease severity in both ADNI and KBASE (Table 1). In ADNI, T and N were associated with lower intercepts in each cognitive domain, V was associated with visuospatial and executive function intercepts, and A with the memory intercept (Table 2). Higher baseline T was associated with decline in each domain, and A was associated with memory decline. In KBASE, T was associated with lower memory and visuospatial intercepts, and N with visuospatial and executive function intercepts (Table 3). No factors (ATNV) were associated with cognitive decline over time in KBASE.

Among ATNV measures, T and N are most strongly associated with cognition in individuals in the US and South Korea. T is most predictive of future cognitive decline in individuals in the US, though not replicated in Korea.

Figures